These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 30562063)
1. Expression and Clinical Significance of CMTM6 in Hepatocellular Carcinoma. Zhu X; Qi G; Li C; Bei C; Tan C; Zhang Y; Shi W; Zeng W; Kong J; Fu Y; Tan S DNA Cell Biol; 2019 Feb; 38(2):193-197. PubMed ID: 30562063 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma. Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005 [No Abstract] [Full Text] [Related]
3. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related]
4. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma. Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
7. [Clinicopathological significance of ezrin and SIX1 protein expression in alpha fetoprotein-negative hepatocellular carcinoma]. Kong J; Zhou X; Han L; Quan C; Cui X; Lin Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Feb; 32(2):236-9. PubMed ID: 26927385 [TBL] [Abstract][Full Text] [Related]
8. CMTM6 Stabilizes PD-L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma. Yugawa K; Itoh S; Yoshizumi T; Iseda N; Tomiyama T; Morinaga A; Toshima T; Harada N; Kohashi K; Oda Y; Mori M Hepatol Commun; 2021 Feb; 5(2):334-348. PubMed ID: 33553979 [TBL] [Abstract][Full Text] [Related]
9. High membrane expression of CMTM6 in hepatocellular carcinoma is associated with tumor recurrence. Muranushi R; Araki K; Yokobori T; Chingunjav B; Hoshino K; Dolgormaa G; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Harimoto N; Shimoda Y; Sano R; Oyama T; Saeki H; Shirabe K Cancer Sci; 2021 Aug; 112(8):3314-3323. PubMed ID: 34080242 [TBL] [Abstract][Full Text] [Related]
10. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection. Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469 [TBL] [Abstract][Full Text] [Related]
11. Expression of β-catenin protein in hepatocellular carcinoma and its relationship with alpha-fetoprotein. Ren YJ; Huang T; Yu HL; Zhang L; He QJ; Xiong ZF; Peng H J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):846-851. PubMed ID: 27924522 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of SOX-1 expression in human hepatocelluar cancer. Lou J; Zhang K; Chen J; Gao Y; Wang R; Chen LB Int J Clin Exp Pathol; 2015; 8(5):5411-8. PubMed ID: 26191244 [TBL] [Abstract][Full Text] [Related]
13. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients. Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882 [TBL] [Abstract][Full Text] [Related]
14. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma. Yin F; Han X; Yao SK; Wang XL; Yang HC World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422 [TBL] [Abstract][Full Text] [Related]
15. Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma. Chen J; Li S; Zhou S; Cao S; Lou Y; Shen H; Yin J; Li G J Cancer Res Ther; 2017; 13(4):651-659. PubMed ID: 28901309 [TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma]. Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
18. The Expression of Dynamin 1, 2, and 3 in Human Hepatocellular Carcinoma and Patient Prognosis. Tian M; Yang X; Li Y; Guo S Med Sci Monit; 2020 Jun; 26():e923359. PubMed ID: 32573516 [TBL] [Abstract][Full Text] [Related]
19. MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma. Xie C; Wu J; Yun J; Lai J; Yuan Y; Gao Z; Li M; Li J; Song L PLoS One; 2013; 8(5):e64235. PubMed ID: 23717574 [TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of cysteinyl leukotriene receptor expression in primary hepatocellular carcinoma]. Sun X; Li J; Ren W; Fang J; Cheng Y; Ji Y Zhonghua Gan Zang Bing Za Zhi; 2015 Dec; 23(12):944-9. PubMed ID: 26739469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]